Sleep disturbances in subjects with asthma and rhinitis”

Phase 1

Recruiting

• Conditions: Rhinitis in Asthma; Respiratory - Asthma

• Registration Number: ACTRN12606000095561
• Lead Sponsor: The Woolcock Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-03-09
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Previous studies show that nearly 100% of patients with asthma also have a nasal inflammation (rhinitis) as part of their generalised airway inflammation, but not all asthma patients have symptoms from their nose. This study, however, evaluates if antiinflammatory treatment of the nose have an effect on sleep, regardless of nasal symptoms or not.Inclusion: medically diagnosed asthma.

Exclusion Criteria

Pre-existing treatment with nasal steroids which is not able to be stoppedKnown obstructive sleep apnoea syndrome (OSAS)Treatment with oral steroidsPrevious hospitalisation (within the last 12 months) for asthmaInhaled steroid dosage exceeding 1000µg/day (fluticasone) or 1600ug/day (budesonide)Treatment with sedativesTreatment with neuroleptic pharamceuticalsNasal polypsSevere septal deviation or turbinate hypertrophy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified